跳至主要内容
临床试验/NCT05003154
NCT05003154Unknown不适用

Comparison of Conventional Mode and Combined Digitalized Mode of Management for Gestational Diabetes Mellitus in China

Women's Hospital School Of Medicine Zhejiang University1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2021年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
46
试验地点
1
主要终点
Concentration of glycosylated hemoglobin A1c

研究概览

简要总结

Gestational diabetes mellitus (GDM) can lead to adverse perinatal and long-term outcomes, and it is so important to manage this disease in pregnancy. Digitalized managements have been proved economical and effective in some chronic diseases like type II diabetes mellitus. The purpose of the current study was to develop and evaluate a digitalized mode for GDM management using mobile healthcare and some wearable devices. Subjects were randomly divided into a conventional management group and combined digitalized management group after diagnosed with GDM during 24-28 weeks of gestation. The conventional mangement group received conventional GDM management and could freely use the mobile healthcare application. The mobile management group received digitalized healthcare services from artificial intelligence under the supervision of obstetricians, in addition to conventional management. The effectiveness of digitalized management were evaluated mainly through the result values of the labotatory tests related to blood glucose controlling and perinatal outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •The age of 18-45 years, single pregnancy, Han nationality;
  • •GDM diagnosed between 24 to 28 weeks of gestation, either of the following: fasting plasma glucose ≥5.1 mmol/L, 60-minute plasma glucose ≥10.0 mmol/L, 120-minute plasma glucose ≥8.5 mmol/L, during a 75g oral glucose tolerance test (OGTT).
  • •Plan to deliver the baby in Women's Hospital School Of Medicine Zhejiang University;
  • •Can operate mobile phones and related software;
  • •Voluntary participation in this study;
  • •Education background: junior high school or above.

排除标准

  • •Type I or II or other non GDM diabetes mellitus;
  • •Severe pregnancy complications or complications: such as malignant tumor, preeclampsia, severe intrahepatic cholestasis of pregnancy syndrome, pregnancy with antiphospholipid antibody syndrome, severe anemia (hemoglobin<90g/L, etc.), cardiac insufficiency cardiovascular disease (such as myocardial infarction, heart failure, pulmonary hypertension, stroke history, coronary heart disease, valvular heart disease, etc.), stroke (moderate), liver disease (such as hepatic insufficiency, acute viral hepatitis, etc.), lung disease (such as restrictive lung disease, emphysema, liver cirrhosis, pulmonary heart disease, etc.), kidney disease (such as nephrotic syndrome, chronic nephritis, renal insufficiency, etc.), chronic hypertension, thyroid disease (such as hyperthyroidism, hypothyroidism, thyroiditis, etc.), other endocrine diseases (such as Cushing's syndrome Acromegaly, venous or arterial thromboembolic diseases, rheumatic immune diseases, etc;
  • •The combined conditions that may affect the diet exercise therapy include severe food allergy, dyskinesia (physical disability), history of bariatric surgery, major gastrointestinal diseases (such as gastrointestinal bleeding, inflammatory bowel disease, gastrointestinal tumor, active stage of peptic ulcer, chronic intestinal obstruction, etc.), restrictive lung disease, history of two or more adverse abortions, placenta previa, repeated and persistent bleeding threatened abortion, threatened premature birth, hyperemesis gravidarum, vegetarians, etc;
  • •Other conditions: such as mental disorders, cervical incompetence, genital tract deformity, etc;
  • •Patients who are taking medicine that may affect glucose metabolism, such as ritodrine, prednisone, etc;
  • •Patients who are participating in other clinical studies;
  • •The researchers believe patients who are not suitable for this study

研究组 & 干预措施

Conventional management group

No Intervention

Received conventional management based on Guidelines for GDM in China

Digitalized management group

Experimental

Reveived conventional management and digitalized management

干预措施: Digitalized management (Other)

结局指标

主要结局

Concentration of glycosylated hemoglobin A1c

时间窗: 37-42 weeks of gestation

Reflecting the average glucose level in the last 8-12 weeks

次要结局

  • Rate of neonate large for gestational age(At the 1 day of delivery)
  • rate of caesarean as the delivery mode(At the 1 day of delivery)
  • Hospitalization cost of neonate and puerperae for delivery(At the 1 day discharging from hospital)
  • Proportion of patients with abnormal resulets of postnatal oral glucose tolerance test(42 days postpartum)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验